INDUSTRY INSIGHTS YOUR PEERS ARE READING
Cannabis Featured Medical Marijuana News Politics DEA fentanyl opioid crisis white houseWhy Is The White House Lying About Marijuana And Fentanyl? MORE
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. It’s been nearly three years since the DEA announced its revolutionary cultivator program. MORE
The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas. MORE
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim. MORE
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim. MORE
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim. MORE
Circuit Court of Appeals that the DEA’s refusal to reschedule cannabis damaged their health and that the federal agency should remove cannabis from Schedule 1. Federal appeals court to DEA: Reconsider marijuana’s Schedule 1 status. MORE
A federal court dismissed a lawsuit against the Drug Enforcement Administration (DEA) on Friday after determining that the agency had fulfilled a requirement to process applications for research-grade marijuana manufacturers. Marijuana Moment reports. MORE
Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government. Additional Resources: Appeal Hearing in Cannabis Lawsuit Against the DEA , Dec. A federal lawsuit against the U.S. Drug Enforcement Administration and the U.S. MORE
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications. MORE
As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs. A Former DEA Prosecutor’s Journey into the Global Cannabis Industry. MORE
DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. Following. The Press Release in full. Department of Justice. MORE
Military.com reports. During a hearing Tuesday on eight VA health-related bills under consideration by Congress, VA officials told House lawmakers that as long as marijuana is illegal under federal law, the department cannot support legislation that promotes its role at the VA. MORE
Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3% On Monday, the U.S. MORE
The Marijuana Time introduce their article by writing… A cannabis researcher at Arizona’s Scottsdale Research Institute plans to sue the Drug Enforcement Administration (DEA) over what she is saying is low-grade cannabis that is unacceptable for testing. MORE
” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. ” Although that ruling ordered DEA to lift the ban, the agency failed to do so. MORE
” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. “[This filing is] asking the court for an order compelling the DEA to process our application. MORE
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action. MORE
DEA Role. DEA will continue to have a role in the hemp program. The regulation requires that testing be done by a DEA registered lab and that in the disposal of hemp above 0.3% must be accomplished under DEA guidance. All lab results are shared information with USDA, which will share information with DEA. Blog Cannabis Cannabis Blog Federal Hemp and CBD Legal Updates Publications DEA famr bill hemp hemp program THC testing usda MORE
The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —. MORE
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. The post The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval? MORE
The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis. The court’s sense of urgency finally puts judicial pressure on the DEA. The DEA is now forced to face the issue. MORE
Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research MORE
Cannabis Medical Marijuana News DEA marijuana research NIDAThe National Institute of Drug Abuse announced plans to grow the largest crop of research marijuana in five years. Continue reading Is The Federal Government Finally Serious About Marijuana Research? at The Fresh Toast. MORE
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. The post Glaucoma And Medical Marijuana: 5 Informative Facts appeared first on The Fresh Toast. MORE
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. Here, DEA can act with little expenditure of resources.”. MORE
We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% cannabidiol cbd dea Drug Enforcement Agency tetrahydrocannabinols THCThe Western District of New York, in Horn v. MORE
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. MORE
You might think it’s California,but actually it is …… According to recently published DEA data about illegal grows it is Kentucky, where both recreational and medical marijuana are still illegal. The DEA confiscated over 1.8 MORE
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 LAW ENFORCEMENT assets DEA eradication legalization seizures MORE
Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. The DEA has routinely denied each petition, or declined to accept it outright. MORE
The DEA is proposing an increase in the amount of cannabis that can be grown for research purposes. Science MORE
Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. MORE
How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. MORE
The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her. MORE
As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” More recently, in 2016, the DEA changed its position and amended regulations in a manner to permit additional applicants to apply to federal licensure to grow marijuana. MORE
DEA Related Topics 
NORML
JULY 16, 2019
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 LAW ENFORCEMENT assets DEA eradication legalization seizures
NORML
AUGUST 26, 2019
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.
NORML
SEPTEMBER 20, 2019
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. It’s been nearly three years since the DEA announced its revolutionary cultivator program.
NORML
OCTOBER 21, 2019
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.
NORML
AUGUST 2, 2019
” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. “[This filing is] asking the court for an order compelling the DEA to process our application.
Leafly
AUGUST 26, 2019
Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research
|
WeedAdvisor
JULY 4, 2019
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. Here, DEA can act with little expenditure of resources.”.
Leafly
MARCH 22, 2019
The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas.
WeedAdvisor
AUGUST 28, 2019
Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action.
CannaTech
JUNE 23, 2019
As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs. A Former DEA Prosecutor’s Journey into the Global Cannabis Industry.
.png)
Cannabis Law Report
AUGUST 24, 2019
The Marijuana Time introduce their article by writing… A cannabis researcher at Arizona’s Scottsdale Research Institute plans to sue the Drug Enforcement Administration (DEA) over what she is saying is low-grade cannabis that is unacceptable for testing.
|
|
Cannabis Law Report
SEPTEMBER 9, 2019
The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.
Cannabis Law Report
NOVEMBER 11, 2019
You might think it’s California,but actually it is …… According to recently published DEA data about illegal grows it is Kentucky, where both recreational and medical marijuana are still illegal. The DEA confiscated over 1.8
WeedAdvisor
JUNE 1, 2019
The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis. The court’s sense of urgency finally puts judicial pressure on the DEA. The DEA is now forced to face the issue.
Cannabis Law Report
AUGUST 26, 2019
DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. Following. The Press Release in full. Department of Justice.
.png)
Canna Law Blog
JUNE 1, 2019
Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. The DEA has routinely denied each petition, or declined to accept it outright.
Cannabis Law Report
JUNE 3, 2019
Circuit Court of Appeals that the DEA’s refusal to reschedule cannabis damaged their health and that the federal agency should remove cannabis from Schedule 1. Federal appeals court to DEA: Reconsider marijuana’s Schedule 1 status.
Cannabis Law Report
OCTOBER 21, 2019
A federal court dismissed a lawsuit against the Drug Enforcement Administration (DEA) on Friday after determining that the agency had fulfilled a requirement to process applications for research-grade marijuana manufacturers. Marijuana Moment reports.
Freedom Leaf
OCTOBER 15, 2018
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. The post The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?
Marijuana Lawyer Blog
JANUARY 12, 2019
Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government. Additional Resources: Appeal Hearing in Cannabis Lawsuit Against the DEA , Dec. A federal lawsuit against the U.S. Drug Enforcement Administration and the U.S.
MJ Business Attorneys
JUNE 29, 2018
Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3% On Monday, the U.S.
NORML
MARCH 1, 2019
” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. ” Although that ruling ordered DEA to lift the ban, the agency failed to do so.
The Blunt Truth
OCTOBER 15, 2019
We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% cannabidiol cbd dea Drug Enforcement Agency tetrahydrocannabinols THCThe Western District of New York, in Horn v.
Cannabis Maven
SEPTEMBER 12, 2019
The DEA is proposing an increase in the amount of cannabis that can be grown for research purposes. Science
The Fresh Toast
APRIL 2, 2019
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health.
The Fresh Toast
MARCH 28, 2019
Cannabis Featured Medical Marijuana News Politics DEA fentanyl opioid crisis white houseWhy Is The White House Lying About Marijuana And Fentanyl?
Greenspoon Marder Cannabis Law Group Blog
OCTOBER 30, 2019
DEA Role. DEA will continue to have a role in the hemp program. The regulation requires that testing be done by a DEA registered lab and that in the disposal of hemp above 0.3% must be accomplished under DEA guidance. All lab results are shared information with USDA, which will share information with DEA. Blog Cannabis Cannabis Blog Federal Hemp and CBD Legal Updates Publications DEA famr bill hemp hemp program THC testing usda
The Fresh Toast
JULY 15, 2019
Cannabis Medical Marijuana News DEA marijuana research NIDAThe National Institute of Drug Abuse announced plans to grow the largest crop of research marijuana in five years. Continue reading Is The Federal Government Finally Serious About Marijuana Research? at The Fresh Toast.
The Fresh Toast
APRIL 2, 2019
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. The post Glaucoma And Medical Marijuana: 5 Informative Facts appeared first on The Fresh Toast.
Cannabis Law Report
MAY 2, 2019
Military.com reports. During a hearing Tuesday on eight VA health-related bills under consideration by Congress, VA officials told House lawmakers that as long as marijuana is illegal under federal law, the department cannot support legislation that promotes its role at the VA.
United Patients Group
AUGUST 21, 2017
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim.
Project CBD
JULY 31, 2018
How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered.
United Patients Group
AUGUST 21, 2017
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim.
United Patients Group
AUGUST 21, 2017
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim.
NORML
JANUARY 17, 2019
As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” More recently, in 2016, the DEA changed its position and amended regulations in a manner to permit additional applicants to apply to federal licensure to grow marijuana.
91 
Let's personalize your content